Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Patients with Lower-Risk Myelodysplastic Syndromes

Blood (2021) 138 (Supplement 1): 2606.

https://doi.org/10.1182/blood-2021-146987

Published: 2021

Journal Articles

Family Reported Outcome Measures and Patient Reported Outcome Measures in Multiple Myeloma Patients

Kareem Midlig, Regina Draliuk, Meir Preis, Barbara Silverman, Mouna Ballan

Blood (2021) 138 (Supplement 1): 3056.

https://doi.org/10.1182/blood-2021-153330

Published: 2021

Journal Articles

Updated Analysis of Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM): The Phase 3 Maia Study

Blood (2020) 136 (Supplement 1): 24–26.

https://doi.org/10.1182/blood-2020-134847

Published: 2020

Journal Articles

Pneumococcal Vaccination (PCV13) Prior to Initiation of Immunosuppressive Therapy in Patients with Hematological Malignancies Is Associated with Decrease Morbidity and Decrease Hospitalizations

Regina Draliuk, MA, Iveta Mintsman, MD, Alla Shnaider, Shuras Viky, Rotem Benami, Noga Salem, Olga Valkovsky, MD, Mouna Ballan Haj, MD, Evelyne Shabad, MD, Antonio Kotler, MD, Elena Mishchenko, MD, Meir Preis, MD PhD

Blood (2018) 132 (Supplement 1): 5919.

https://doi.org/10.1182/blood-2018-99-118483

Published: 2018

Journal Articles

Factor XI Deficiency Is Not Associated with Increased Risk of Pneumonia in Adults

Ophira Salomon, MD, Meir Preis, MD PhD, Antonio Kotler, MD, Nili Stein, Walid Saliba, MD

Blood (2017) 130 (Supplement 1): 2365.

https://doi.org/10.1182/blood.V130.Suppl_1.2365.2365

Published: 2017

Journal Articles

Prothrombin "Carmel": Identification of a Novel Homozygous Mutation in the Prothrombin Gene Causing Coagulation Factor II Deficiency and Inherited Bleeding Disorder in an Israeli Arab Family

Emad Muhammad, PhD, Aliza Cassel, PhD, Miriam Berl, Meir Preis, MD PhD, Ayala Rozano Gorelick, MD

Blood (2017) 130 (Supplement 1): 4872.

https://doi.org/10.1182/blood.V130.Suppl_1.4872.4872

Published: 2017

Journal Articles

Risk for Major Bleeding in Patients with Severe Factor XI Deficiency Treated with Aspirin and Clopidogrel

Shoshan Perek, MD, Antonio Kotler, MD, Shai Cohen, MD, Gad Rennert, MDPhD, Nili Stein, Walid Saliba, MD, Meir Preis, MD PhD

Blood (2017) 130 (Supplement 1): 3670.

https://doi.org/10.1182/blood.V130.Suppl_1.3670.3670

Published: 2017

Journal Articles

The Risk for Major Cardiovascular Event and Venous Thromboembolism in Patients with Factor VII and Factor V Deficiency.

Amir Warwar, MD, Antonio Kotler, MD, Shai Cohen, MD, Gad Rennert, MDPhD, Nili Stein, Meir Preis, MD PhD, Walid Saliba, MD

Blood (2017) 130 (Supplement 1): 1090.

https://doi.org/10.1182/blood.V130.Suppl_1.1090.1090

Published: 2017

Journal Articles

Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events

Meir Preis, Julianna Hirsch, Antonio Kotler, Ahmad Zoabi, Nili Stein, Gad Rennert, Walid Saliba

Blood (2017) 129 (9): 1210–1215.

https://doi.org/10.1182/blood-2016-09-742262

Published: 2017

Journal Articles

Inherited Factor XI Deficiency Is Associated with Decrease Risk for Cardiovascular Adverse Event and Venous Thromboembolism - Israeli Population Based Study

Meir Preis, MD PhD, Julianna Hirsch, MD, Antonio Kotler, MD, Nili Stein, Ahmad Zoabi, MD, Walid Saliba, MD

Blood (2016) 128 (22): 1387.

https://doi.org/10.1182/blood.V128.22.1387.1387

Published: 2016

Journal Articles

Identification and Characterization of a New Mutation in Coagulation Factor VII (Carmel mutation), with Different Reactivity Towards Tissue Factors of Different Origin

Aliza Cassel, PhD, Nurit Rosenberg, PhD, Emad Muhammad, PhD, Rima Dazdik, PhD, Miriam Berl, Meir Preis, MD PhD

Blood (2016) 128 (22): 1396.

https://doi.org/10.1182/blood.V128.22.1396.1396

Published: 2016

Journal Articles

Integrating Palliative Care in Outpatient Hematology Clinic Increases Patient Satisfaction, Adherence to Care and Decrease Hospital Admissions

Regina Draliuk, MA, RN, Elisabeth Perez, MA, Alexander Yosipovich, MD, Meir Preis, MD PhD

Blood (2016) 128 (22): 4785.

https://doi.org/10.1182/blood.V128.22.4785.4785

Published: 2016

Journal Articles

Integrative Approach Successfully Improves Safety of in-Patient Chemotherapy and Reduces Health Care Costs

Meir Preis, MDPhD, Ziad Abu-Salah, Ravit Melberger, Leah Zack, Judith Mohilever, Limor Cohen, Judith Shwartz, Shai Cohen, MD, Ophir Lavon, MD, Yamit Musai, Sharon Alroy Preis, MD MPH

Blood (2015) 126 (23): 4524.

https://doi.org/10.1182/blood.V126.23.4524.4524

Published: 2015

Journal Articles

Microrna Expression In Patients With Myelodysplastic Syndromes Treated With Demethylating Agents

Meir Preis, MD, PhD, Gregory J Tsongalis, PhD, Christopher H. Lowrey, MD, Deborah L. Ornstein, MD

Blood (2013) 122 (21): 3758.

https://doi.org/10.1182/blood.V122.21.3758.3758

Published: 2013

NARROW

Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Patients with Lower-Risk Myelodysplastic Syndromes

Family Reported Outcome Measures and Patient Reported Outcome Measures in Multiple Myeloma Patients

Updated Analysis of Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM): The Phase 3 Maia Study

Pneumococcal Vaccination (PCV13) Prior to Initiation of Immunosuppressive Therapy in Patients with Hematological Malignancies Is Associated with Decrease Morbidity and Decrease Hospitalizations

Factor XI Deficiency Is Not Associated with Increased Risk of Pneumonia in Adults

Prothrombin "Carmel": Identification of a Novel Homozygous Mutation in the Prothrombin Gene Causing Coagulation Factor II Deficiency and Inherited Bleeding Disorder in an Israeli Arab Family

Risk for Major Bleeding in Patients with Severe Factor XI Deficiency Treated with Aspirin and Clopidogrel

The Risk for Major Cardiovascular Event and Venous Thromboembolism in Patients with Factor VII and Factor V Deficiency.

Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events

Inherited Factor XI Deficiency Is Associated with Decrease Risk for Cardiovascular Adverse Event and Venous Thromboembolism - Israeli Population Based Study

Identification and Characterization of a New Mutation in Coagulation Factor VII (Carmel mutation), with Different Reactivity Towards Tissue Factors of Different Origin

Integrating Palliative Care in Outpatient Hematology Clinic Increases Patient Satisfaction, Adherence to Care and Decrease Hospital Admissions

Integrative Approach Successfully Improves Safety of in-Patient Chemotherapy and Reduces Health Care Costs

Microrna Expression In Patients With Myelodysplastic Syndromes Treated With Demethylating Agents

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only